WHAT WE DO
Frontier Diagnostics is looking at redefining how researchers study cancer biology. With our advanced liquid biopsy platform, we are developing tools to capture and analyse circulating tumour cells (CTCs), opening new opportunities to investigate tumour dynamics at stages that may precede conventional methods of detection. Our research solutions will empower scientists to explore the potential for earlier insights and more individualised approaches in oncology.
WHY IT MATTERS
RESEARCH INTO PERSONALISED APPROACHES
Unlocking the potential to research how therapies might be matched to individual patient profiles—even before treatment begins. Research into circulating tumour cells (CTCs) is opening new avenues to investigate tumour biology and therapeutic response.
Fast, Non-Invasive Tests
Imagine a future with no biopsies. Just a simple blood draw.
Continuous Monitoring
Explore the potential to study tumour dynamics in real time and provide researchers with new insights that may inform future approaches in oncology. The tests will soon be available as Research Use Only, however registration as an IVD is in progress.
SERVICES
IN-HOUSE SAMPLE PROCESSING (RESEARCH USE ONLY)
For participating research sites, samples will be submitted to our laboratory for processing and return of research data within approximately 5 working days.
ON-SITE RESEARCH ANALYSIS
Larger laboratories and research sites will be able to use our Quantum FluoScope device for same-day on-site sample analysis under research use conditions.
